MedTrace Logo

Calanus Oil Supplementation and Maximal Oxygen Uptake

NCT02908828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2020-09-30

No results posted yet for this study

Summary

Copepod oil is extracted from the marine copepod Calanus finmarchicus, the dominant plankton species in the marine food web in the Norwegian Sea. Copepods constitute the largest renewable and harvestable resource in the Norwegian Sea and adjacent waters, and it is now developed knowledge and technology for sustainable harvesting of this "new" resource. The purpose of this study is to investigate whether Calanus copepod oil supplementation has an equivalent effect on maximal oxygen uptake in humans to that seen in experimental studies in mice.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Calanus oil

DIETARY_SUPPLEMENT

placebo dietary oil

Sponsors & Collaborators

  • University of Tromso

    collaborator OTHER

  • Calanus

    collaborator INDUSTRY

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Ulrik Wisløff, phd prof · Norwegian University of Science and Technology

  • Trine Karlsen, phd · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-09-19
Completion
2017-09-19

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02908828 on ClinicalTrials.gov